We are live on ! Find out more
HMC

Harvard Management Company Portfolio holdings

AUM $1.82B
1-Year Est. Return 26.23%
This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+26.23%
3 Year Est. Return
+156.3%
5 Year Est. Return
+133.98%
10 Year Est. Return
+221.37%
AUM
$807M
AUM Growth
+$2.88M
Cap. Flow
+$4.91M
Cap. Flow %
0.61%
Top 10 Hldgs %
81.37%
Holding
47
New
–
Increased
2
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
GRAB icon
Grab
GRAB
+$10.7M
2
IRON icon
Disc Medicine
IRON
+$830K

Top Sells

Rank Stock Value
1
EQRX
EQRx, Inc. Common Stock
EQRX
+$5.55M
2
LAUR icon
Laureate Education
LAUR
+$1.07M

Sector Composition

Rank Sector Weight
1 Communication Services 43.32%
2 Consumer Discretionary 19.46%
3 Healthcare 17%
4 Technology 15.72%
5 Financials 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$3.91T
$213M 26.38%
2,411,540
– –
LNW
2
DELISTED
Light & Wonder
LNW
$157M 19.46%
2,678,571
– –
META icon
3
Meta Platforms (Facebook)
META
$1.51T
$137M 16.95%
1,135,916
– –
GRAB icon
4
Grab
GRAB
$13.5B
$42M 5.2%
13,036,482
+3,734,992
+40% +$10.7M
ABCL icon
5
AbCellera Biologics
ABCL
$1.62B
$41.6M 5.16%
4,105,095
– –
PCTTW
6
PureCycle Technologies Inc Warrant
PCTTW
$9.5M
$16.9M 2.09%
714,285
– –
RVMD icon
7
Revolution Medicines
RVMD
$40.2B
$16M 1.98%
670,382
– –
RXRX icon
8
Recursion Pharmaceuticals
RXRX
$1.57B
$11.6M 1.44%
1,509,254
– –
ASML icon
9
ASML
ASML
$675B
$11M 1.37%
20,186
– –
PLRX icon
10
Pliant Therapeutics
PLRX
$67.5M
$10.9M 1.35%
562,379
– –
MEKA
11
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
$9.97M 1.24%
1,000,000
– –
NVDA icon
12
NVIDIA
NVDA
$5.01T
$9.7M 1.2%
663,680
– –
QRVO icon
13
Qorvo
QRVO
$7.63B
$9.49M 1.18%
104,669
– –
EQRX
14
DELISTED
EQRx, Inc. Common Stock
EQRX
$9.48M 1.18%
3,853,367
-1,408,794
-27% -$5.55M
ADI icon
15
Analog Devices
ADI
$181B
$8.95M 1.11%
54,568
– –
AMAT icon
16
Applied Materials
AMAT
$426B
$8.61M 1.07%
88,443
– –
RLAY icon
17
Relay Therapeutics
RLAY
$4.02B
$8.08M 1%
541,124
– –
LRCX icon
18
Lam Research
LRCX
$382B
$8.04M 1%
191,310
– –
TSM icon
19
TSMC
TSM
$2.09T
$7.99M 0.99%
107,294
– –
AMD icon
20
Advanced Micro Devices
AMD
$851B
$7.26M 0.9%
112,137
– –
TXG icon
21
10x Genomics
TXG
$5.87B
$6.78M 0.84%
186,143
– –
INTC icon
22
Intel
INTC
$466B
$5.49M 0.68%
207,752
– –
MU icon
23
Micron Technology
MU
$1.04T
$5.37M 0.67%
107,522
– –
TNGX icon
24
Tango Therapeutics
TNGX
$4.34B
$5.14M 0.64%
708,385
– –
RKLB icon
25
Rocket Lab Corp
RKLB
$39.9B
$3.77M 0.47%
1,000,000
– –
1
2

Similar funds

DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $1.82B AUM 19.69% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return
DE
Diversified Enterprises Wilmington, Delaware $1.83B AUM 16.79% 1-Year Est. Return
SI
Standard Investments New York $1.83B AUM 4.12% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Harvard Management Company's Q4 2022 Portfolio in Review

As of Q4 2022, Harvard Management Company held 47 positions worth $807M, up 0.36% from $804M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 2.1%. Harvard Management Company opened no new positions and exited 1, leaving the 47-position portfolio largely intact.

By sector, the portfolio is most concentrated in Communication Services at 43% of assets, down from 48% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Harvard Management Company added most to Grab in Q4 2022, an estimated $10.7M increase.
  • Harvard Management Company's biggest Q4 2022 reduction was EQRx, Inc. Common Stock, cutting an estimated $5.55M.
  • Harvard Management Company fully exited Laureate Education in Q4 2022, selling an estimated $1.07M.
  • Harvard Management Company's ten largest holdings make up 81% of its $807M portfolio in Q4 2022.
  • Harvard Management Company opened 0 new positions and closed 1 in Q4 2022.
  • Harvard Management Company's portfolio value rose 0.36% quarter-over-quarter to $807M.

Based on Harvard Management Company's 13F filing for Q4 2022, filed 10 Feb 2023.